|
Liraglutide Reduces BMI in Children Under 12 With Obesity, But Questions Remain
|
Written by: J. Smith |
Hits: 788
|
|
Dexcom G7 15-Day CGM Wins FDA Clearance
|
Written by: J. Smith |
Hits: 1588
|
|
Rybelsus® Cuts Cardiovascular Risk by 14% in SOUL Trial
|
Written by: J. Smith |
Hits: 1149
|
|
Ozempic® Shows New Benefit for People with Type 2 Diabetes and PAD
|
Written by: J. Smith |
Hits: 1417
|
|
Novo Nordisk Strikes $2 Billion Deal for Potential Rival to Lilly’s Triple Agonist Drug
|
Written by: J. Smith |
Hits: 1093
|
|
Novo Nordisk Expands $499 Wegovy® Offer to Retail Pharmacies
|
Written by: J. Smith |
Hits: 766
|
|
Dexcom Receives FDA Warning Letter Over Manufacturing Issues
|
Written by: J. Smith |
Hits: 1481
|
|
Novo Nordisk’s CagriSema Falls Short of Weight Loss Expectations in REDEFINE 2 Trial
|
Written by: J. Smith |
Hits: 1277
|
|
Novo Nordisk Launches $499 Cash Program for Wegovy, Matching Eli Lilly’s Zepbound Pricing
|
Written by: J. Smith |
Hits: 923
|
|
Lilly Prepares for High Demand With $550M Stockpile of Oral GLP-1
|
Written by: J. Smith |
Hits: 851
|
